dual agonist glp 1 PDB-101: Molecule of the Month: GLP-1 Receptor Agonists Engineering a potent and long-acting
Description
95% CI 0.35, 3.14)
Here, we provide a comprehensive review of the therapeutic potential of incretin mimetics and insulin in AD and PD.
To evaluate changes in time-in-therapeutic INR range (TTR) among warfarin patients initiated on GLP-1 RA therapy
Looking for a safe, affordable way to lose weight with real results
Issue 42 of The Altascientist explores GLP-1 receptor agonist drug development, covering preclinical models, bioanalytical assays, clinical study design, and manufacturing
Participants Patients with type 2 diabetes
